Skip to content

US · MMED · MEDICAL - EQUIPMENT & SERVICES

MiniMed Group, Inc. Common Stock (MMED) intrinsic value and stock valuation

$16.01as of 2026-11-21 · Mkt cap 5.21B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

MiniMed Group, Inc. Common Stock DCF and intrinsic value

InvestorsCraft values MMED with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from MMED’s statements →

MiniMed Group, Inc. Common Stock Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Equipment & Services Northridge, CA 91325 minimed.com

How the business is doing

Fiscal 2023–2026, USD

Revenue
$3.1B
20232026
Net income
-$-331M
20232026
Free cash flow
-$-420M
20232026
Total equity
$3.61B
20242026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2023–2026, USD
2026202520242023
Revenue$3.1B$2.72B$2.47B$2.25B
Operating income$49M-$-202M-$-69M-$-69M
Net income-$-331M-$-250M-$-112M-$-96M
EPSd-$-1.29M-$-890.28K-$-398.85K-$-341.87K
Operating cash flow-$-197M$140M$41M-$-6M
Capital expenditure-$-223M-$-193M-$-148M-$-167M
Free cash flow-$-420M-$-53M-$-107M-$-173M
Total assets$4.63B$4.2B$4.09B—
Total debt$145M$11M$8M—
Net debt-$-153M$0.00-$-46M—
Total equity$3.61B$3.33B$3.45B—
Cash and short-term investments$298M$11M$54M—
Income statement
2026202520242023
Revenue$3.1B$2.72B$2.47B$2.25B
Cost of revenue$1.42B$1.19B$1.03B$937M
Gross profit$1.68B$1.53B$1.44B$1.31B
Research and development expenses$448M$438M$437M$429M
Selling, general and administrative expenses$1.18B$1.13B$1.06B$960M
Other expenses$0.00$158M$12M-$-12M
Operating expenses$1.63B$1.73B$1.51B$1.38B
Cost and expenses$3.05B$2.92B$2.54B$2.31B
Interest income$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00
Depreciation and amortization$0.00$143M$129M$115M
Ebitda$49M$107M$59M$39M
Operating income$49M-$-202M-$-69M-$-69M
Total other income/expenses, net-$-236M-$-1M-$-1M-$-7M
Income before tax-$-187M-$-203M-$-70M-$-76M
Income tax expense$128M$48M$38M$16M
Net income-$-331M-$-250M-$-112M-$-96M
Weighted average shares outstanding$256.6M$280.8M$280.8M$280.8M
Weighted average diluted shares outstanding$256.6M$280.8M$280.8M$280.8M
Balance sheet
202620252024
Cash and short-term investments$298M$11M$54M
Net receivables$655M$570M$507M
Inventory$341M$310M$292M
Total current assets$1.35B$939M$895M
Property, plant and equipment, net$711M$706M$636M
Goodwill and intangible assets$2.36B$2.39B$2.42B
Long-term investments$0.00$0.00$0.00
Total non-current assets$3.28B$3.26B$3.2B
Total assets$4.63B$4.2B$4.09B
Accounts payable$163M$205M$190M
Short-term debt$145M$11M$8M
Deferred revenue$15M$11M$11M
Total current liabilities$702M$710M$518M
Long-term debt$0.00$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00
Total non-current liabilities$317M$160M$128M
Capital lease obligations$8M$11M$8M
Total liabilities$1.02B$870M$646M
Common stock$3M$0.00$0.00
Retained earnings-$-116M$0.00$0.00
Accumulated other comprehensive income (loss)-$-12M$3M-$-16M
Total equity$3.61B$3.33B$3.45B
Total investments$0.00$0.00$0.00
Total debt$145M$11M$8M
Net debt-$-153M$0.00-$-46M
Cash flow statement
2026202520242023
Net income-$-317M-$-198M-$-107M-$-92M
Depreciation and amortization$156M$143M$129M$115M
Stock-based compensation$46M$41M$38M$35M
Change in working capital-$-166M$122M-$-74M-$-90M
Accounts receivable-$-538M-$-66M-$-105M-$-70M
Inventory-$-29M-$-19M$5M-$-28M
Accounts payable$41M$191M-$-4M$14M
Net cash provided by operating activities-$-197M$140M$41M-$-6M
Investments in property, plant and equipment-$-223M-$-193M-$-148M-$-167M
Acquisitions, net$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-233M-$-193M-$-157M-$-180M
Common stock issued$538M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00
Net cash used for financing activities$716M$10M$112M$185M
Net change in cash$287M-$-43M-$-4M-$-2M
Cash at end of period$298M$11M$54M$58M
Operating cash flow-$-197M$140M$41M-$-6M
Capital expenditure-$-223M-$-193M-$-148M-$-167M
Free cash flow-$-420M-$-53M-$-107M-$-173M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About MiniMed Group, Inc. Common Stock

        MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

        CEO
        Que Thanh Dallara
        Employees
        8K
        Beta
        -3.68

        Explore

        Frequently asked questions

        What is the intrinsic value of MiniMed Group, Inc. Common Stock (MMED)?

        MiniMed Group, Inc. Common Stock (MMED) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is MMED undervalued?

        MMED trades at a price of $16.01 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.